FDA.reportPublic FDA data

Evrysdi 0.75 MG/mL Oral Solution

RxCUI
2390946
RxNorm name
Evrysdi 0.75 MG/mL Oral Solution
Display name
Evrysdi 0.75 MG/mL Oral Solution
Full name
Evrysdi 0.75 MG/mL Oral Solution
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EVRYSDIRISDIPLAMGenentech, Inc.eceb9a99-7191-4be5-87c3-0102707cf98e2026-02-19Adverse reactionsExact identifier
rxcui: 2390946

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
eceb9a99-7191-4be5-87c3-0102707cf98eEvrysdi 0.75 MG/mL Oral Solution [PSN] · risdiplam 0.75 MG/ML Oral Solution [Evrysdi] [SBD] · Evrysdi 0.75 MG/ML Oral Solution [SY] · Evrysdi 60 MG per 80 ML Oral Solution [SY]426These highlights do not include all the information needed to use EVRYSDI safely and effectively. See full prescribing information for EVRYSDI. EVRYSDI ® (risdiplam) for oral solution EVRYSDI ® (risdiplam) tablets, for oral use Initial U.S. Approval: 202020260219